NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Akili, Inc. (NASDAQ: AKLI), relating to a tender offer from Vital Therapeutics Corporation. Under the terms of the agreement, Vital Therapeutics Corporation will acquire all the outstanding shares of Akili common stock for $0.4340 cash per share.
ACT NOW: The tender offer will expire on July 31, 2024.
Click here for more information https://monteverdelaw.com/case/akili-inc/. It is free and there is no cost or obligation to you.
Before you hire a law firm, you should talk to a lawyer and ask:
- Do you file class actions and go to Court?
- When was the last time you recovered money for shareholders?
- What cases did you recover money in and how much?
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
- Allego Announces Framework Agreement with Kempower Delivering the Next Generation of High Power Charging Across Europe - July 2, 2025
- Akropolis Group Audit Committee Reappointed for a New Four-Year Term - July 2, 2025
- GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch - July 2, 2025
